Key Facts

Lilly at a Glance

(as of March 31, 2020)

  • A heritage more than 140 years strong: company founded on May 10, 1876

  • Headquarters located in Indianapolis, Indiana, U.S.A.

  • Approximately 34,000 employees worldwide

  • More than 7,700 employees engaged in research and development

  • Clinical research conducted in more than 55 countries

  • Research and development facilities in 8 countries

  • Research and development expenditure of $5,595 million USD in 2019 ($21.5 million/workday)

  • Research and development as a percentage of sales in 2019: 25.1%

  • Percentage of total workforce engaged in research and development in 2019: 23%

  • Manufacturing plants in 8 countries

  • Products marketed in 120 countries

Snapshot of Lilly Canada

(as of December 31, 2019)

  • Founded in 1938 as a result of a collaboration between Eli Lilly and Company and Banting and Best, which produced the world’s first commercially available insulin

  • Approximately 340 employees

  • Managed research at 313 sites across Canada

  • Almost $54.5 million CAD of research and development, including a milestone payment to Zymeworks and sums acknowledged by the PMPRB

  • More than $28.2 million in community support including grants, fellowships, charitable donations, medical education programs, and free medicine distributed through our compassionate access programs

Cost of Pharmaceuticals

  • Average cost to discover and develop a new drug: $2.6 billion USD

  • Average length of time from discovery to patient: 10 years

Lilly Canada office reception desk and seating area

Lilly in Canada

Who We Are

Woman smiling looking off camera

Operating Responsibly

Our Responsibility Efforts